Business ❯ Pharmaceuticals ❯ Mergers and Acquisitions

Bidding Wars

Avadel Pharmaceuticals Novo Nordisk

Lundbeck Challenges Alkermes With Up to $23-Per-Share Offer for Avadel

Analysts say the richer bid pressures Alkermes to decide its next move.